SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000893838-05-000119
Filing Date
2005-05-17
Accepted
2005-05-17 21:24:51
Documents
2
Period of Report
2005-05-13

Document Format Files

Seq Description Document Type Size
1 rexahnfrm3mcintosh051605_ex.html 3  
1 rexahnfrm3mcintosh051605_ex.xml 3 2245
2 poamcintosh.txt EX-24 2326
  Complete submission text file 0000893838-05-000119.txt   6465
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address (240) 268-5300
McIntosh David M (Reporting) CIK: 0001317248 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50590 | Film No.: 05840128